All studies
RecruitingTherapeutic exploratory (Phase II)Interventional

Antioxidant Treatment with Vitamin C in Cardiac Surgery Patients – A Pilot Randomized Controlled Trial

Major heart surgery places a great deal of stress on the body. This stress causes inflammation, which can sometimes slow down recovery or lead to complications in the intensive care unit (ICU). This pilot study is testing a high-dose liquid form of vitamin C (called Pascorbin) given through a vein. Vitamin C is a powerful antioxidant that helps protect cells from damage. Researchers want to find out if giving this treatment around the time of surgery lowers swelling and chemical stress in the blood. Adults having open-heart surgery may be invited to take part. Doctors will measure inflammation levels during the first three days after surgery. They will also track how quickly patients recover, how long they need breathing machines, and their health over the following six months. The overall goal is to see if this simple treatment makes heart surgery safer.

At a glance

Status
Recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
GCP-Service International West GmbH
Enrolment target
60
Start
28 May 2024

What is this study about?

Having open-heart surgery is a major event for the body. Even though it is life-saving, the operation naturally triggers a strong reaction from your immune system. This reaction causes inflammation, where the body releases chemical signals that can sometimes put extra strain on the heart, lungs, and kidneys during recovery in intensive care.

Vitamin C is a familiar nutrient, but in high medical doses given directly into the bloodstream, it acts as an antioxidant. This means it may help neutralise harmful molecules produced during surgery. Researchers hope that by calming this sudden wave of inflammation, patients might experience fewer complications, spend less time on breathing machines, and leave hospital sooner.

This is a Phase II pilot clinical trial, which means it is an early exploratory study designed to test whether the treatment works as expected and is safe. Doctors will closely monitor blood markers of inflammation—particularly a protein called interleukin-6 (IL-6)—over the first 72 hours after surgery.

By comparing patients who receive the vitamin C infusion with those who receive standard care, the study team hopes to learn whether this treatment should be tested in larger numbers of surgical patients in the future.

Key takeaways

  • Tests whether high-dose vitamin C can lower inflammation after open-heart surgery.
  • Open to adults aged 18 and older who are due to have planned cardiac surgery.
  • Treatment is given through a vein around the time of the operation.
  • Doctors will monitor blood markers, heart function, and recovery over 6 months.
  • Participation is entirely voluntary and will not disrupt your essential surgical care.

Who may be eligible?

This study is open to adults aged 18 and over who are scheduled to have open-heart surgery and will need care in an intensive care unit (ICU) afterwards. Both men and women can take part.

Before you can join, the hospital medical team will carefully review your health records. They will check your general fitness, heart condition, and kidney health to make sure receiving high doses of vitamin C is safe for you.

People with certain pre-existing conditions, such as severe kidney disease or specific metabolic disorders that react poorly to high-dose vitamin C, will not be able to participate. Your surgical team will confirm whether the trial is suitable for your individual circumstances.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I am scheduled to have open-heart surgery.
  3. I will be staying in an intensive care unit (ICU) after my operation.
  4. I do not have severe kidney problems that prevent me from receiving extra vitamin C.
  5. I am willing to have blood tests taken during the first three days of my recovery.
Answer every question to see your result.

What does participation involve?

If you decide to take part, the trial treatment will fit closely into your normal hospital stay. You will receive the vitamin C solution (or standard care/placebo) through a drip directly into a vein around the time of your surgery and during your initial recovery.

While you are in the intensive care unit, the clinical team will take small blood samples over the first 72 hours to measure your body's inflammation levels. They will also carry out routine checks on your heart rhythm, kidney function, and breathing support. These checks are very similar to the standard care you would receive anyway in the ICU.

After you leave intensive care and return home, the study team will keep track of your health. You may be contacted for follow-up reviews at 30 days and at 6 months after your surgery to see how well you have recovered. In total, your active participation lasts around 6 months.

Potential risks and benefits

High-dose vitamin C is generally well tolerated, but like any medical treatment, it carries potential risks. Some people might experience mild side effects such as temporary irritation around the drip site, stomach upset, or changes in urine tests. Because this is a clinical trial, there is no guarantee that you will receive a direct personal health benefit from taking part. However, your involvement could help doctors discover safer ways to care for future heart surgery patients. Taking part is entirely voluntary, and you are free to leave the trial at any time without your standard medical care being affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Germany

Common questions

Why is vitamin C being used for heart surgery patients?

Surgery causes temporary chemical stress and inflammation in the body. Vitamin C works as an antioxidant that may help neutralise this stress and protect delicate tissues.

Is this the same as taking vitamin C tablets at home?

No. The trial uses a specialised, high-strength liquid given directly into a vein so that the body can absorb it quickly and at exact medical levels.

Will taking part delay my heart operation?

No. The study treatment and tests are carefully timed to fit alongside your scheduled surgery and standard hospital routine.

Could I receive a dummy treatment instead of vitamin C?

Yes. This is a randomised trial, which means you may be randomly assigned to receive either the vitamin C infusion or a standard dummy treatment (placebo) so doctors can make a fair comparison.

Can I leave the study if I change my mind?

Yes, you can withdraw at any point without giving a reason. Your doctors will continue to give you the highest standard of normal NHS care.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Antioxidant Treatment with Vitamin C in Cardiac Surgery Pati…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.